Research progress in the characterization of amino acid metabolism in frailty patients

doi:10.16352/j.issn.1001-6325.2025.02.0253

Abstract

Abstract: Frailty is a complex aging syndrome characterized by diminished strength and physiological dysfunction. Early diagnosis of frailty is of great value in helping the elderly to improve the quality of life. However, specific biological markers to diagnose frailty are still lacking. In recent years, moderate protein intake has been shown to be an effective intervention in the management of frailty in older adults, and the relationship between frailty and amino acid metabolism has received widespread attention. This review discusses recent advances in the study of the mechanisms by which amino acid metabolism affects frailty and provide new ideas for searching specific biomarkers of frailty.

Key words: frailty, amino acid metabolism, diagnose

CLC Number:

R592

WU Huishan, LIAO Yingping, LI Meng. Research progress in the characterization of amino acid metabolism in frailty patients[J]. Basic & Clinical Medicine, 2025, 45(2): 253-257.

References 25

[1]	Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype[J]. J Gerontol A Biol Sci Med Sci, 2001, 56: 146-156.
[2]	Westbrook R,Zhang C,Yang H,et al. Metabolomics-based identification of metabolic dysfunction in frailty[J]. J Gerontol A Biol Sci Med Sci,2022,77:2367-2372.
[3]	Calvani R, Picca A, Marini F,et al. Identification of biomarkers for physical frailty and sarcopenia through a new multi-marker approach: results from the biosphere study[J]. Geroscience,2021, 43:727-740.
[4]	Zhou M, Wei Y, Feng Y,et al. Arginine regulates skeletal muscle fiber type formation via mTOR signaling pathway[J]. Int J Mol Sci, 2024,25:6184. doi: 10.3390/ijms25116184.
[5]	Mone P,Pansini A,Jankauskas SS,et al. L-arginine improves cognitive impairment in hypertensive frail older adults[J]. Front Cardiovasc Med,2022,9:868521. doi: 10.3389/fcvm.2022.868521.
[6]	Calvani R,Rodriguez-mañas L,Picca A,et al. Identifi-cation of a circulating amino acid signature in frail older persons with type 2 diabetes mellitus:results from the metabofrail study[J]. Nutrients,2020,12. doi: 10.3390/nu12010199.
[7]	Matsue Y,Kamiya K,Saito H,et al. Prevalence and prognostic impact of the coexistence of multiple frailty domains in elderly patients with heart failure:the FRAGILE-HF cohort study[J]. Eur J Heart Fail,2020,22:2112-2119.
[8]	Le Couteur DG,Ribeiro R,Senior A,et al. Branched chain amino acids,cardiometabolic risk factors and outcomes in older men:the concord health and ageing in men project[J]. J Gerontol A Biol Sci Med Sci,2020,75:1805-1810.
[9]	Adachi Y,Ono N,Imaizumi A,et al. Plasma amino acid profile in severely frail elderly patients in Japan[J]. Int J Gerontol,2018,12:290-230.
[10]	Kochlik B,Franz K,Henning T,et al. Frailty is characterized by biomarker patterns reflecting inflammation or muscle catabolism in multi-morbid patients[J]. J Cachexia Sarcopenia Muscle,2023,14:157-166.
[11]	Hamrick MW, Isales CM. Special issue: the kynurenine pathway in aging[J]. Exp Gerontol,2020,134:110895. doi: 10.1016/j.exger.2020.110895.
[12]	Marron M,Harris T,Boudreau R,et al. Metabolites associated with vigor to frailty among community-dwelling older black men[J]. Metabolites,2019,9. doi: 10.3390/metabo9050083.
[13]	Corona G,Polesel J,Fratino L,et al. Metabolomics biomarkers of frailty in elderly breast cancer patients[J]. J Cell Physiol,2014,229:898-902.
[14]	Kameda M,Teruya T,Yanagida M,et al. Frailty markers comprise blood metabolites involved in antioxidation, cognition, and mobility[J]. Proc Nati Acad Sci USA,2020,117:9483-9489.
[15]	Pan Y,Li Y,Liu P,et al. Metabolomics-based frailty biomarkers in older Chinese adults[J]. Front Med (Lausanne),2021,8:830723. doi: 10.3389/fmed.2021.830723.
[16]	Zhou M, Sun W, Chu J, et al. Identification of novel biomarkers for frailty diagnosis via serum amino acids metabolomic analysis using UPLC-MS/MS[J]. Proteomics Clin Appl, 2024, 18: e2300035. doi: 10.1002/prca.202300035.
[17]	Wyse ATS, Dos Santos TM, Seminotti B, et al. Insights from animal models on the pathophysiology of hyperphenylalaninemia: role of mitochondrial dysfunction, oxidative stress and inflammation[J]. Mol Neurobiol, 2021,58:2897-2909.
[18]	Zhou Q,Sun WW,Chen JC,et al. Phenylalanine impairs insulin signaling and inhibits glucose uptake through modification of IRβ[J]. Nat Commun,2022,13:4291. doi: 10.1038/s41467-022-32000-0.
[19]	Czibik G,Mezdari Z,Murat Altinas D,et al. Dysregulated phenylalanine catabolism plays a key role in the trajectory of cardiac aging[J]. Circulation,2021,144:559-574.
[20]	Kondoh H,Kameda M,Yanagida M. Whole blood metabolomics in aging research[J]. Int J Mol Sci,2020,22:175. doi: 10.3390/ijms22010175.
[21]	Boirie Y, Pinel A, Guillet C. Protein and amino acids in obesity: friends or foes?[J]. Curr Opin Clin Nutr Metab Care,2023,26:508-513.
[22]	Moaddel R,Fabbri E,Khadeer MA,et al. Plasma biomarkers of poor muscle quality in older men and women from the baltimore longitudinal study of aging[J]. J Gerontol A Biol Sci Med Sci,2016,71:1266-1272.
[23]	Fazelzadeh P,Hangelbroek RW,Tieland M,et al. The muscle metabolome differs between healthy and frail older adults[J]. J Proteome Res,2016,15:499-509.
[24]	Voulgaridou G,Papadopoulou SD,Spanoudaki M,et al. Increasing muscle mass in elders through diet and exercise: a literature review of recent RCTs[J]. Foods, 2023,12:1218. doi: 10.3390/foods12061218.
[25]	Pujos-guillot E,Pétéra M,Jacquemin J,et al. Identifica-tion of pre-frailty sub-phenotypes in elderly using metabolomics[J]. Front Physiol,2018,9:1903. doi: 10.3389/fphys.2018.01903.